Terms: = Thyroid cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
103 results:
1. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
Wang H; Zhang C; Li Q; Tian T; Huang R; Qiu J; Tian R
BMC Cancer; 2024 Apr; 24(1):427. PubMed ID: 38589799
[TBL] [Abstract] [Full Text] [Related]
2. Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast cancer Registry.
Iwamoto T; Kumamaru H; Niikura N; Sagara Y; Miyashita M; Konishi T; Sanuki N; Tanakura K; Nagahashi M; Hayashi N; Yoshida M; Watanabe C; Kinukawa N; Toi M; Saji S
Breast Cancer; 2024 Mar; 31(2):185-194. PubMed ID: 38319565
[TBL] [Abstract] [Full Text] [Related]
3. [Diagnostic Value of American thyroid Association Guidelines,American College of Radiology thyroid Imaging Reporting and Data System,and Chinese thyroid Imaging Reporting and Data System Alone and Combined With BRAF
Lin Y; Luo YK; Li J; Ren XY; Wang HW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
[TBL] [Abstract] [Full Text] [Related]
4. Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive Review.
Yoo WS; Ku EJ; Lee EK; Ahn HY
Endocrinol Metab (Seoul); 2023 Dec; 38(6):750-759. PubMed ID: 37956967
[TBL] [Abstract] [Full Text] [Related]
5. [A single-center study on the oncological outcomes of active surveillance of thyroid nodules measuring≤1 cm with highly suspicious ultrasound features].
Liu CH; Zhao H; Xia Y; Cao Y; Zhang LY; Zhao Y; Gao LY; Liu RF; Liu YW; Liu HF; Meng ZL; Liu SZ; Lu Y; Palashate Y; Li XY
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(40):3186-3192. PubMed ID: 37879872
[No Abstract] [Full Text] [Related]
6. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary thyroid cancer.
Xie W; Li H; Lin Q; Ke N
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
[TBL] [Abstract] [Full Text] [Related]
7. Mitochondrial-related genes markers that predict survival in patients with head and neck squamous cell carcinoma affect immunomodulation through hypoxia, glycolysis, and angiogenesis pathways.
Li Z; Cai H; Zheng J; Chen X; Liu G; Lv Y; Ye H; Cai G
Aging (Albany NY); 2023 Oct; 15(19):10347-10369. PubMed ID: 37796226
[TBL] [Abstract] [Full Text] [Related]
8. The auxiliary diagnosis of thyroid echogenic foci based on a deep learning segmentation model: A two-center study.
Liu Y; Chen C; Wang K; Zhang M; Yan Y; Sui L; Yao J; Zhu X; Wang H; Pan Q; Wang Y; Liang P; Xu D
Eur J Radiol; 2023 Oct; 167():111033. PubMed ID: 37595399
[TBL] [Abstract] [Full Text] [Related]
9. Facilitation of Definitive cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With thyroid Nodules.
Fu G; Chazen RS; Monteiro E; Vescan A; Freeman JL; Witterick IJ; MacMillan C
JAMA Netw Open; 2023 Jul; 6(7):e2323500. PubMed ID: 37505499
[TBL] [Abstract] [Full Text] [Related]
10. ccnd1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma.
Li Z; Qiu X; He Q; Fu X; Ji F; Tian X
Sci Rep; 2023 Jul; 13(1):11831. PubMed ID: 37481637
[TBL] [Abstract] [Full Text] [Related]
11. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
12. A clinical and molecular pathology prediction model for central lymph node metastasis in cN0 papillary thyroid microcarcinoma.
Ma T; Wang L; Zhang X; Shi Y
Front Endocrinol (Lausanne); 2023; 14():1075598. PubMed ID: 36817603
[TBL] [Abstract] [Full Text] [Related]
13. Association between urinary iodine concentration and the risk of papillary thyroid cancer by sex and age: a case-control study.
Hwang Y; Oh HK; Chung JH; Kim SW; Kim JH; Kim JS; Shin MH
Sci Rep; 2023 Feb; 13(1):2041. PubMed ID: 36739467
[TBL] [Abstract] [Full Text] [Related]
14. [Correlations of serum TgAb and TPOAb and clinicopathological features of PTC in children and adolescents].
Huang DM; Zhi JT; Zhang JM; Zheng XQ; Zhao JZ; Wei SF; Gao M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1418-1425. PubMed ID: 36707945
[No Abstract] [Full Text] [Related]
15. Possible Association Between thyroid Nodule Formation and Developmental Alterations in the Pituitary-thyroid Hormone Axis in Children and Adolescents: The Fukushima Health Management Survey.
Suzuki S; Suzuki S; Iwadate M; Matsuzuka T; Shimura H; Ohira T; Furuya F; Suzuki S; Yasumura S; Yokoya S; Ohto H; Kamiya K
Thyroid; 2022 Nov; 32(11):1316-1327. PubMed ID: 36066342
[No Abstract] [Full Text] [Related]
16. Prognostic significance of inflammatory markers LMR, PLR, MPV, FIB in intermediate-and high-risk papillary thyroid carcinoma.
Li C; Li J; Li S; Zhao Y; Liu G; Du R; Dionigi G; Liang N; Sun H
Front Endocrinol (Lausanne); 2022; 13():984157. PubMed ID: 36060974
[TBL] [Abstract] [Full Text] [Related]
17. Prognosis of Patients with 1-4 cm Papillary thyroid cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles.
Jang A; Jin M; Kim WW; Jeon MJ; Sung TY; Song DE; Kim TY; Chung KW; Kim WB; Shong YK; Lee YM; Kim WG
Ann Surg Oncol; 2022 Nov; 29(12):7835-7842. PubMed ID: 35907995
[TBL] [Abstract] [Full Text] [Related]
18. MTHFD1L knockdown diminished cells growth in papillary thyroid cancer.
Yi D; Yilihamu Y; Jiang C; Wang R; Lu X; Sang J; Su L
Tissue Cell; 2022 Aug; 77():101869. PubMed ID: 35870426
[TBL] [Abstract] [Full Text] [Related]
19. A prospective study to evaluate the treatment effect of pulsed dye laser on thyroidectomy hypertrophic scars using 3D imaging analysis.
Kim JC; Choi JW; Kim YC
Lasers Surg Med; 2022 Oct; 54(8):1082-1088. PubMed ID: 35842822
[TBL] [Abstract] [Full Text] [Related]
20. Circular RNA_0006014 promotes breast cancer progression through sponging miR-885-3p to regulate NTRK2 and PIK3/AKT pathway.
Zhou X; Jian W; Luo Q; Zheng W; Deng X; Wang X; Borkhuu O; Ji C; Li D; Fang L
Aging (Albany NY); 2022 Apr; 14(7):3105-3128. PubMed ID: 35383130
[TBL] [Abstract] [Full Text] [Related]
[Next]
